EW 📈 Edwards Lifesciences - Overview

Edwards Lifesciences Corp is a leading provider of innovative products and technologies for the treatment of structural heart disease and critical care monitoring, with a global presence spanning the United States, Europe, Japan, and other international markets. The company's product portfolio includes a range of transcatheter heart valve replacement and repair solutions, such as the Edwards SAPIEN family of valves system, which enables minimally invasive replacement of aortic heart valves. Additionally, the company offers transcatheter heart valve repair and replacement products, including the PASCAL PRECISION and Cardioband systems, designed to treat mitral and tricuspid valve diseases.

The company's surgical structural heart solutions include aortic surgical valves, such as the INSPIRIS and INSPIRIS RESILLA valves, which feature RESILIA tissue and VFit technology for improved durability and performance. Edwards Lifesciences also offers pre-assembled tissue valves conduits, like the KONECT RESILIA, designed for complex combined procedures, as well as the MITRIS RESILIA valve. These solutions cater to the needs of cardiac surgeons and patients undergoing open-heart surgery, providing a range of options for aortic and mitral valve replacement and repair.

In the critical care segment, Edwards Lifesciences provides a suite of monitoring solutions, including hemodynamic monitoring systems that measure a patient's heart function and fluid status in surgical and intensive care settings. Products like FloTrac, Acumen IQ sensors, ClearSight, and ForeSight enable clinicians to make informed decisions about patient care. The company's HemoSphere monitoring platform displays physiological information, while the Acumen Hypotension Prediction Index software alerts clinicians to potential hypotension, allowing for proactive intervention. These critical care solutions are designed to enhance patient outcomes and improve the efficiency of care in high-acuity settings.

Edwards Lifesciences distributes its products through a combination of direct sales force and independent distributors, ensuring broad reach and accessibility to its innovative solutions. With a history dating back to 1958, the company has established itself as a pioneer in the field of cardiovascular medicine, with a strong commitment to research and development, and a focus on delivering high-quality products that address the evolving needs of patients and clinicians. Headquartered in Irvine, California, Edwards Lifesciences Corp is a publicly traded company, listed on the New York Stock Exchange under the ticker symbol EW, with a web presence at https://www.edwards.com, and is classified as a common stock under the GICS Sub Industry of Health Care Equipment, with the ISIN code US28176E1082.